Ranjit S. Bindra

Also affiliated with Johns Hopkins University, Yale Cancer Center, Yale University, University of New Haven, Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 26 papers. Top paper: “Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer”.

Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer

Cancer(2020)10.1002/cncr.32914

N/A

2.1DataRank · unranked

44 citations

Shantao Li, Harvey A. Risch, Ranjit S. Bindra, Patrick D. McGillivray, Mark Gerstein +1 more

Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

Nanotechnology(2022)10.1088/1361-6528/ac9683

N/A

0.497DataRank · unranked

10 citations

Ranjit S. Bindra, W. Mark Saltzman, Alexander Josowitz

Decreased miR-24-3p potentiates DNA damage responses and increases susceptibility to COPD

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.22.108688

N/A

0DataRank · unranked

2 citations

Feng Wan, Eric Finnemore, Willy Roque, Sojin Kim, Isabel Bazán +13 more

Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity

Translational Oncology(2021)10.1016/j.tranon.2021.101147

N/A

0DataRank · unranked

59 citations

Jillian Eckroate, Ranjini K. Sundaram, Ryan B. Jensen, Ranjit S. Bindra, Jennifer Garbarino

Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma

Journal of Pharmacology and Experimental Therapeutics(2021)10.1124/jpet.121.000845

N/A

0DataRank · unranked

45 citations

Wenjuan Zhang, Danielle M. Burgenske, Minjee Kim, Afroz S. Mohammad, Sonja Dragojevic +5 more

Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors

NAR Cancer(2021)10.1093/narcan/zcab018

N/A

0DataRank · unranked

33 citations

Jinny Van Doorn, Ranjini K. Sundaram, Sachita Ganesa, Juan C. Vasquez, Ranjit S. Bindra +1 more

Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity

NAR Cancer(2021)10.1093/narcan/zcab021

N/A

0DataRank · unranked

30 citations

Robert J. Aiello, Nalin Leelatian, Jason M. Beckta, Jane Bechtold, Patricia Bourassa +19 more

Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore

Oncotarget(2021)10.18632/oncotarget.27933

N/A

0DataRank · unranked

3 citations

James Herrington, Adam Hendricson, Piyasena Hewawasam, Mark P. Plummer, Denton Hoyer +4 more

Correction to ‘Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity’

NAR Cancer(2021)10.1093/narcan/zcab047

N/A

0DataRank · unranked

1 citations

Robert J. Aiello, Nalin Leelatian, Jason M. Beckta, Jane Bechtold, Patricia Bourassa +19 more

TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-1000

N/A

0DataRank · unranked

55 citations

Yasuhisa Murai, Keli Agama, Yilun Sun, Liton Kumar Saha, Xi Yang +11 more

Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma

Scientific Reports(2022)10.1038/s41598-022-09614-x

N/A

0DataRank · unranked

24 citations

Amrita Sule, Ranjini K. Sundaram, Ranjit S. Bindra, Sachita Ganesa

Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.31.478549

N/A

0DataRank · unranked

9 citations

Shipra Malik, Hee‐Won Suh, Yong Xiao, Yanxiang Deng, Rong Fan +5 more

Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy

Science Advances(2023)10.1126/sciadv.abq7459

N/A

0DataRank · unranked

43 citations

Shipra Malik, Hee‐Won Suh, Yong Xiao, Yanxiang Deng, Rong Fan +6 more

Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma

Science Translational Medicine(2023)10.1126/scitranslmed.adi1617

N/A

0DataRank · unranked

28 citations

Ju-Hyun Lee, Teresa Lee, Hee‐Won Suh, Supum Lee, Alessandra Cavaliere +14 more

Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0045

N/A

0DataRank · unranked

7 citations

Janie Y. Zhang, Wei Wei, Jeffrey Sklar, Jill Lacy, Minghao Zhong +11 more

Mechanism of Action of KL-50, a Novel Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers

ChemRxiv(2023)10.26434/chemrxiv-2023-zwj94

N/A

0DataRank · unranked

1 citations

Anna Lo, Olga Fedorova, James L. Elia, Susan Gueble, Kingson Lin +15 more

The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma

Neuro-Oncology(2024)10.1093/neuonc/noae257

N/A

0DataRank · unranked

9 citations

Thomas Sears, Wenxia Wang, Rahul K. Chaliparambil, Shejuan An, Jann N. Sarkaria +6 more

Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers

Journal of the American Chemical Society(2024)10.1021/jacs.3c06483

N/A

0DataRank · unranked

7 citations

Anna Lo, Olga Fedorova, James L. Elia, Susan E. Gueble, Kingson Lin +13 more

NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion

Molecular Cancer Research(2024)10.1158/1541-7786.mcr-23-1003

N/A

0DataRank · unranked

5 citations

Karlie N. Lucas, Sateja Paradkar, Joseph Edmonds, Sam Friedman, Matthew A. Murray +12 more

Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0012

N/A

0DataRank · unranked

7 citations

Katelyn J. Noronha, Yazhe Wang, Anna P. Friedman, Sateja Paradkar, Hee‐Won Suh +5 more

PARG inhibition induces nuclear aggregation of PARylated PARP1

Structure(2024)10.1016/j.str.2024.09.006

N/A

0DataRank · unranked

4 citations

Julia Purcell, Annie Cui, Samuel R. Friedman, Katelyn J. Noronha, Matthew A. Murray +4 more

Mismatch repair deficiency drives malignant progression and alters the tumor immune microenvironment in glioblastoma models

Journal of Clinical Investigation(2025)10.1172/jci195189

N/A

0DataRank · unranked

1 citations

Nishant Soni, Seung-Won Choi, Kavita Rawat, Tanvi Joshi, Sam Friedman +20 more

Novel Strategies for Improved Treatment of O6-Methylguanine-DNA Methyltransferase Promoter-Methylated Glioma

Medical Research Archives(2025)10.18103/mra.v13i9.6944

N/A

0DataRank · unranked

1 citations

Ranjit S. Bindra, Susan Gueble, Juan C. Vasquez

DNA damage response profile distinguishes poor-acting gliomas with shared methylome signatures

Neuro-Oncology(2025)10.1093/neuonc/noaf199

N/A

0DataRank · unranked

0 citations

Charu Singh, Richard Bouffard, Ranjini K. Sundaram, Kirsten E. Diggins, William Sullivan +7 more

Synthesis and Biological Evaluation of Colibactin Derivatives

ACS Chemical Biology(2025)10.1021/acschembio.5c00639

N/A

0DataRank · unranked

0 citations

Olga Fedorova, Collin D. Heer, Matthew G. Rees, Melissa M. Ronan, Jennifer A. Roth +3 more

MicroRNA miR-24-3p reduces DNA damage responses, apoptosis, and susceptibility to chronic obstructive pulmonary disease

JCI Insight(2020)10.1172/jci.insight.134218

N/A

0DataRank · unranked

40 citations

Feng Wan, Eric Finnemore, Willy Roque, Sojin Kim, Isabel Bazán +15 more